Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia
- 1 January 2008
- journal article
- clinical trial
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 49 (10) , 1916-1924
Abstract
Intensive chemotherapy is mandatory in curative treatment of acute myeloid leukemia (AML), but whether the nutritional status deteriorates during treatment, is unknown. We therefore prospectively examined anthropometric and biochemical nutritional markers during intensive chemotherapy in 26 Russian and 19 Norwegian AML patients during 9 months from diagnosis. Although the body mass index remained unchanged in both cohorts, hand grip strength and triceps skinfold thickness declined (P < 0.05) during treatment before normalisation at study end. We detected a similar significant, temporary decrease in albumin, transferrin, testosterone and gonadotrophins in both cohorts. Although the fat-soluble vitamins D and E also displayed such a pattern, vitamin A dropped and remained low throughout the study in both cohorts. The Russian patients reported lower global quality of life, more symptoms and more financial concern than the Norwegians. Our data suggest a catabolic metabolism during intensive chemotherapy for AML, leading to impaired nutritional status, hypofunction of the pituitary–gonadal axis and decreased health-related quality of life.Keywords
This publication has 31 references indexed in Scilit:
- Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemiaBlood, 2007
- Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort studyBMJ, 2007
- Adult Health In The Russian Federation: More Than Just A Health ProblemHealth Affairs, 2007
- Malnutrition and Infection: Complex Mechanisms and Global ImpactsPLOS Medicine, 2007
- Handgrip strength as a hospital admission nutritional risk screening methodEuropean Journal of Clinical Nutrition, 2007
- Hemodialysis and Peritoneal DialysisClinical Journal of the American Society of Nephrology, 2006
- Outcome of patients with acute myelogenous leukemia after second salvage therapyCancer, 2005
- Effect of 1,25(OH)2Vitamin D3Analogs on Differentiation Induction and Cytokine Modulation in Blasts from Acute Myeloid Leukemia PatientsLeukemia & Lymphoma, 2004
- Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differencesEuropean Journal of Haematology, 2004
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993